Sanofi buoyed as FDA approves Multaq and backs Lantus

Sanofi-Aventis has received a major boost with the news that regulators in the USA have approved its cardiovascular drug Multaq and a launch across the Atlantic will take place over the summer

GSK spends £23.2 million to bag B-MS products in Middle East

GlaxoSmithKline is continuing with its strategy of expanding in the emerging markets and has acquired the branded generics business of Bristol-Myers Squibb in five Middle East countries